Baxter International Inc. Share Price Berne S.E.
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
38.11 CHF | +3.50% | -.--% | -.--% |
Sales 2024 * | 15.11B 13.56B 1,195B | Sales 2025 * | 15.66B 14.05B 1,239B | Capitalization | 17.27B 15.49B 1,366B |
---|---|---|---|---|---|
Net income 2024 * | 703M 631M 55.59B | Net income 2025 * | 950M 852M 75.12B | EV / Sales 2024 * | 1.79 x |
Net Debt 2024 * | 9.85B 8.83B 779B | Net Debt 2025 * | 9.06B 8.12B 716B | EV / Sales 2025 * | 1.68 x |
P/E ratio 2024 * |
18.4
x | P/E ratio 2025 * |
15.1
x | Employees | - |
Yield 2024 * |
3.52% | Yield 2025 * |
3.66% | Free-Float | 74.27% |
Latest transcript on Baxter International Inc.
1 day | +3.50% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 30/09/15 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 17/10/23 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 05/02/17 |
Peter Wilver
BRD | Director/Board Member | 64 | 09/05/22 |
Director/Board Member | 64 | 17/02/19 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.72% | 182B | |
-2.83% | 103B | |
-5.01% | 66.94B | |
+15.53% | 46.73B | |
-8.53% | 45.14B | |
+5.82% | 41.57B | |
+17.67% | 30.48B | |
+14.00% | 24.26B | |
-8.08% | 23.58B |
- Stock Market
- Equities
- BAX Stock
- BAX Stock